• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jubilant Pharmova Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Jubilant Bhartia
  • BSE Code : 592.0
  • ISIN : INE700A01033
1,158.40 -36 (-2.99%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,150.50

  • Today’s High

    1,194.30

  • Open

    1,180.00

  • Perv Close

    1,194.10

  • 52W Low

    778.60

  • 52W High

    1,309.90

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    18,453.31

  • Div & Yield %

    0.43

  • Book Value(₹)

    145.52

  • Debt-Equity Ratio

    -2.99

  • AGM Date

    01-Aug-2025

  • EPS

    1.31

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    18,453.31

  • RONW (%)

    0.76

  • ROCE (%)

    6.37

Score Board

  • Equity (₹ in Cr.)

    15.93

  • BV (₹)

    145.50

  • Sales( ₹ in Cr.)

    231.20

  • NP (in Cr.)

    22.20

  • NP Var(%)

    -31.0

  • Div%

    500.0

  • CPS (₹)

    1.80

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    18,488.36

  • 52 Week High

    1,309.90

  • 52 Week Low

    778.60

  • Price BSE

    1161.0

  • Price NSE

    1,158.00

  • Market Capital( in Cr.)

    18,488.36

  • P/C Ratio

    642.20

  • P/E Ratio

    833.10

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 784.70 810.10 725.73 2,709.50 3,139.90 3,438.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 784.70 810.10 725.73 2,709.50 3,139.90 3,438.61
Other Income 103.40 137.90 126.16 47.88 173.23 78.00
Stock Adjustments -39.00 -3.50 40.61 -55.21 108.32 -46.74
Total Income 849.10 944.50 892.50 2,702.17 3,421.45 3,469.87
EXPENDITURE :            
Raw Materials 316.50 411.10 372.89 1,395.15 1,792.74 2,006.07
Power and Fuel Cost 68.40 75.40 62.31 280.40 369.20 358.28
Employee Cost 190.00 167.30 163.64 220.67 264.90 265.71
Other Manufacturing Expenses 59.60 49.00 39.80 216.91 269.07 255.24
Selling and Administration Expenses 88.60 93.00 111.59 100.02 143.14 138.82
Miscellaneous Expenses 6.10 7.70 9.65 14.07 39.96 46.87
Employee Benefit Expenses 190.00 167.30 163.64 220.67 264.90 265.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 729.20 803.50 759.88 2,227.23 2,879.02 3,070.99
Operating Profit 119.90 141.00 132.62 474.94 542.44 398.87
Interest 29.90 18.50 10.99 101.80 136.20 128.96
Gross Profit 90.00 122.50 121.63 373.14 406.24 269.91
Depreciation 48.30 43.20 36.91 99.97 107.40 86.48
Profit Before Tax 41.70 79.30 84.72 273.17 298.84 183.43
Current Tax 6.80 13.80 14.28 45.44 26.13 31.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.30 15.60 -10.05 13.25 -48.43 4.72
Reported Net Profit 31.60 49.90 80.49 214.48 321.14 147.63
Extraordinary Items -0.76 0.25 0.02 -0.19 -4.92 -4.47
Adjusted Net Profit 32.36 49.65 80.47 214.67 326.06 152.10
Adjustment below Net Profit 0.00 -0.70 0.81 -212.82 -3.49 -9.46
P & L Balance brought forward 1,123.60 1,154.00 1,152.37 1,153.26 986.93 951.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 79.60 79.60 79.64 0.00 151.32 102.95
P & L Balance carried down 1,075.60 1,123.60 1,154.03 1,154.92 1,153.26 986.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 500.00 500.00 500.00 450.00
Dividend Per Share(Rs) 5.00 5.00 5.00 5.00 5.00 4.50
Earnings Per Share-Unit Curr 1.99 3.14 5.05 13.46 20.16 9.27
Earnings Per Share(Adj)-Unit Curr 1.99 3.14 5.05 13.46 17.49 8.04
Book Value 149.34 151.86 153.11 80.51 163.67 146.91
Book Value(Adj)-Unit Curr 149.34 151.86 153.11 80.51 142.03 127.49

Shareholding Pattern

  • Promoter Group

    47.68%

  • Public Share Holding

    51.77%

  • Custodian

    0.56%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 5,230,455 3.28 5,230,455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5,000 5,000.00 5,000 5,000
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5,235,455 3.29 5,235,455 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 68,804,742 43.20 68,804,742 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,898,425 1.19 1,898,425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 70,703,167 44.39 70,703,167 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,645 0.00 2,045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,721,494 17.40 27,721,494 189
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,834,727 1.15 1,834,727 3
Mutual Funds / UTI 9,570,367 6.01 9,570,367 17
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,764,616 2.36 3,764,616 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 42,893,849 26.93 42,893,249 233
2] Non Institution
Bodies Corporate 5,452,847 3.42 5,452,597 791
Clearing Members 339,520 0.21 339,520 27
Directors of their Relatives 2,794 0.00 2,794 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,806,996 1.13 1,785,841 2,862
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 843,215 0.53 843,215 1,697
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,472,000 6.57 10,472,000 3
Individuals holding nominal share capital up to Rs. 1 lakh 18,154,371 11.40 17,794,986 93,935
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,641 0.01 18,641 9
Others 1,987,353 1.25 1,987,353 1
Sub Total 39,564,258 24.84 39,183,468 99,428
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 884,410 0.56 884,410 1
Total Shares held by Custodians and against which Depository Receipts have been issued 884,410 0.56 884,410 1
Grand Total ( A + B + C ) 159,281,139 100.00 158,899,749 99,673

Company Background

Jubilant Pharmova LtdPharmaceuticals - Indian - Bulk Drugs

  • Jubilant Pharmova Ltd
  • BSE Code : 592.0
  • ISIN : INE700A01033

  • Incorporation Year

    1978

  • Registered Office

    Bhartiagram Gajraula
    , Amroha,
    Uttar Pradesh-244223

  • Telephone

    91-5924-267200

  • FAX

    91-5924-4264895/96

  • Chairman

    Shyam S Bhartia

  • Managing Director

    Priyavrat Bhartia

  • Company Secretary

    Naresh Kapoor

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit Heights ,
    1E/13 Jhandewalan Ex,
    Mumbai - New Delhi-110055

Jubilant Pharmova Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jubilant Pharmo 1,160.60 888.10 784.70 525.16 2.57
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10